Bosutinib in the management of chronic myelogenous leukemia
Gunhild Keller-von Amsberg, Philippe SchafhausenDepartment of Hematology and Oncology and, Stem Cell Transplantation and Pulmonology Division, Oncological Center, University Hospital Hamburg-Eppendorf, Hamburg, GermanyAbstract: Bosutinib (SKI-606) is an orally available, once-daily dual Src and Abl...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-05-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/bosutinib-in-the-management-of-chronic-myelogenous-leukemia-a12959 |